A.G. Montalban et al. / Inorganica Chimica Acta 317 (2001) 143–148
145
umax (log m) 399 (4.66), 662 (4.77) nm; 1H NMR
(270 MHz, pyridine-d5) l 1.47 (s, 18H), 1.50 (s, 36H),
5.15 (s, 5H), 7.01–7.19 (m, 15H), 7.78 (d, J=8.5 Hz,
4H), 7.80 (d, J=8.3 Hz, 4H), 7.86 (d, J=8.3 Hz, 4H),
8.00 (m, 2H), 8.72 (d, J=8.5 Hz, 4H), 8.76 (d, J=
8.3 Hz, 4H), 8.90 (d, J=8.3 Hz, 4H), 10.00 (m, 2H),
10.10 (m, 2H); MS (FAB) m/z 1804 [M−Cl]+. Anal.
Found: C, 72.62; H, 5.73; N, 9.50. Calc. for
(d, J=8.2 Hz, 4H), 7.82 (d, J=8.2 Hz, 4H), 8.03 (dd,
J=5.7 and 8.2 Hz, 2H), 8.18 (d, J=5.9 Hz, 2H), 8.28
(d, J=6.2 Hz, 2H), 8.72 (d, J=8.2 Hz, 4H), 8.77 (d,
J=8.2 Hz, 4H), 8.84 (d, J=8.4 Hz, 4H), 9.73 (d, J=
5.7 Hz, 4H), 10.24 (d, J=8.2 Hz, 2H); MS (FAB) m/z
1972 [M−2Cl]+. HRMS (FT-ICR) calc. for
C124H132MgN16Ru: [M−2Cl]2+
[M−2Cl]2+, 985.4807.
,
985.4858; found:
C111H104ClN12PRuZn: C, 72.47; H, 5.70; N, 9.14%.
2.8. [(Zn[pz(t-butylphenyl)6 phen])Ru(bpy*)2]Cl2 (15)
2.6. [(Zn[pz(t-butylphenyl)6 phen])Ru(p-cymene)Cl]Cl
(12)
Treatment of porphyrazine 6 (40.0 mg, 29.0 mmol)
under the same reaction conditions as above gave
complex 15 (6.7 mg, 11%) as a dark-green solid: m.p.
\350°C; Rf 0.06 (CHCl3:MeOH 9:1); IR (CH2Cl2)
1739, 1612, 1481, 1368, 1264, 1245, 1138, 1105, 982,
842 cm−1; UV–Vis (CH2Cl2) umax (log m) 399 (4.77),
[RuCl(m2-Cl)(p-cymene)]2 (10) (22 mg, 36.3 mmol)
was added to porphyrazine 6 (25 mg, 18.1 mmol) in
DMF (4 ml), the mixture heated at 80°C for 5 h under
N2, cooled, rotary evaporated and the dark-green
residue taken up in CH2Cl2 (20 ml) and filtered. Ro-
tary evaporation and chromatography on alumina
(CHCl3:MeOH 9:1) followed by gel filtration (Sep-
hadex, CHCl3) gave complex 12 (3.4 mg, 11%) as a
1
460sh, 673 (4.88) nm; H NMR (270 MHz, CDCl3) l
1.31 (s, 18H), 1.37 (s, 18H), 1.42 (s, 18H), 1.50 (s,
36H), 7.37 (d, J=7.9 Hz, 2H), 7.45 (d, J=6.9 Hz,
2H), 7.77 (d, J=8.2 Hz, 4H), 7.79 (d, J=8.2 Hz, 4H),
7.81 (d, J=8.2 Hz, 4H), 8.03 (dd, J=5.4 and 8.1 Hz,
2H), 8.16 (d, J=5.4 Hz, 2H), 8.26 (d, J=5.7 Hz, 2H),
8.71 (d, J=8.2 Hz, 4H), 8.75 (d, J=8.2 Hz, 4H), 8.84
(d, J=8.2 Hz, 4H), 9.76 (br s, 4H), 10.25 (d, J=
8.1 Hz, 2H); MS (FAB) m/z 2013 [M−2Cl]+. HRMS
dark-green
solid:
m.p.
\350°C;
Rf
0.20
(CHCl3:MeOH 9:1); IR (CH2Cl2) 1731, 1606, 1489,
1366, 1264, 987, 779 cm−1; UV–Vis (CH2Cl2) umax
1
(log m) 390 (4.97), 668 (4.95) nm; H NMR (270 MHz,
pyridine-d5) l 1.06 (d, J=6.8 Hz, 6H), 1.45 (s, 18H),
1.50 (s, 36H), 2.36 (s, 3H), 2.85 (h, J=6.8 Hz, 1H),
6.32 (d, J=6.2 Hz, 2H), 6.54 (d, J=6.2 Hz, 2H), 7.77
(d, J=8.4 Hz, 4H), 7.80 (d, J=8.4 Hz, 4H), 7.85 (d,
J=8.4 Hz, 4H), 8.38 (dd, J=4.9 and 8.4 Hz, 2H),
8.72 (d, J=8.4 Hz, 4H), 8.76 (d, J=8.4 Hz, 4H), 8.87
(d, J=8.4 Hz, 4H), 10.30 (d, J=8.4 Hz, 2H), 10.35
(d, J=4.9 Hz, 2H); MS (FAB) m/z 1646 [M−Cl]+.
Anal. Found: C, 67.95; H, 6.12. Calc. for
C98H98Cl2N12RuZn·3H2O: C, 67.82; H, 6.12%.
(FT-ICR) calc. for C124H132N16RuZn: [M−2Cl]2+
1005.4578; found: [M−2Cl]2+, 1005.4533.
,
2.9. (Mg[pz(t-butylphenyl)6 phen])3RuCl2 (16)
RuCl3·H2O (4.0 mg, 19.2 mmol), LiCl (2.5 mg,
57.6 mmol) and EtOH (five drops) were added to a
solution of porphyrazine 5 (90.0 mg, 67.4 mmol) in
DMF (5 ml), and the mixture heated at reflux for 10 h
under N2. The solution was allowed to cool and the
dark-green precipitate that formed upon the addition
of H2O (13 ml) filtered and washed with H2O. Chro-
matography of the crude residue on alumina (CH2Cl2;
CHCl3:MeOH 9:1) followed by gel filtration (Bio-
Beads, CH2Cl2 then Sephadex, CHCl3) gave com-
pound 16 (80.0 mg, 56%) as a dark-green solid: m.p.
\350°C; Rf 0.40 (CHCl3:MeOH 5.7:1); IR (CH2Cl2)
2.7. [(Mg[pz(t-butylphenyl)6 phen])Ru(bpy*)2]Cl2 (14)
cis-RuCl2(bpy*)2
(13)
(41.0 mg,
58.0 mmol)
(bipy*=4,4%-di-tert-butyl-2,2%-bipyridine) was added to
porphyrazine 5 (40.0 mg, 29.9 mmol) in DMF (4 ml),
and the mixture heated at reflux for 4 h under N2. The
mixture was allowed to cool, rotary evaporated and
the dark-green residue was dissolved in CH2Cl2 (20 ml)
and filtered. Rotary evaporation and chromatography
on alumina (CH2Cl2; CHCl3:MeOH 9:1) followed by
gel filtration (Sephadex, CHCl3) gave complex 14
(19.2 mg, 31%) as a dark-green solid: m.p. \350°C;
Rf 0.23 (CHCl3:MeOH 5.7:1); IR (CH2Cl2) 1726, 1612,
1605, 1478, 1366, 1245, 1138, 1104, 986, 841 cm−1
;
UV–Vis (CH2Cl2) umax (log m) 385 (5.32), 459 (4.75),
673 (5.33) nm; 1H NMR (270 MHz, pyridine-d5) l
1.49 (s, 54H), 1.50 (s, 108H), 7.74–7.90 (m, 36H), 8.28
(m, 6H), 8.75 (t, J=7.9 Hz, 24H), 8.85 (d, J=7.7 Hz,
12H), 9.14 (d, J=4.0 Hz, 6H), 10.42 (d, J=8.2 Hz,
6H); HRMS (FT-ICR) calc. for C264H253Mg3N36Ru:
1480, 1368, 1264, 1245, 1137, 1105, 983, 842 cm−1
;
UV–Vis (CH2Cl2) umax (log m) 390 (4.88), 460sh, 672
1
(4.89) nm; H NMR (270 MHz, pyridine-d5) l 1.31 (s,
[M+H−2Cl]3+, 1366.9833; found: [M+H−2Cl]3+
,
18H), 1.37 (s, 18H), 1.43 (s, 18H), 1.50 (s, 18H), 1.51
(s, 18H), 7.38 (dd, J=1.5 and 6.2 Hz, 2H), 7.46 (dd,
J=1.5 and 5.9 Hz, 2H), 7.77 (d, J=8.4 Hz, 4H), 7.79
1367.0006. Anal. Found: C, 76.06; H, 6.24; N, 11.99.
Calc. for C264H252Cl2Mg3N36Ru: C, 75.97; H, 6.08; N,
12.08%.